FDA approves first over-the-counter hormonal contraception capsule

The Meals and Drug Administration introduced on Thursday morning its approval of the progestin-only oral contraceptive Opill for over-the-counter use.

“In the present day’s approval marks the primary time a nonprescription day by day oral contraceptive can be an accessible choice for hundreds of thousands of individuals in the US,” stated the Director of the FDA's Heart for Drug Analysis and Analysis, Patrizia Cavazzoni.

This choice comes after an advisory panel in Might unanimously supported the proposal to grant over-the-counter approval to the Irish-based firm Perrigo's contraceptive.

"When correctly used, Opill is protected and efficient," the FDA stated.

This can be a growing story.